<DOC>
	<DOCNO>NCT01419184</DOCNO>
	<brief_summary>This real-world , prospective , open-label , multicenter study participant randomize ( 1:1 ) receive intravenous ( IV ) vancomycin IV daptomycin . The purpose study compare infection-related hospital length stay , along number participant-reported outcome , participant complicate skin soft tissue infection treat daptomycin vancomycin .</brief_summary>
	<brief_title>Daptomycin Versus Vancomycin Participants With Skin Infections Due MRSA</brief_title>
	<detailed_description>Eligible participant recruit within 24 hour hospital admission cSSSI due suspect documented Methicillin-resistant Staphylococcus Aureus ( MRSA ) , anticipated require IV antibiotic effective MRSA least 3 day hospitalization management cSSSI . The primary objective compare infection-related hospital length stay participant treat daptomycin vancomycin . Secondary objective compare participant report outcome ( pain symptom Health Related Quality Life ) , 30 day cSSSI-related hospital readmission rate , cSSSI-related medical resource utilization cost participant treat daptomycin vancomycin .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Staphylococcal Infections</mesh_term>
	<mesh_term>Skin Diseases , Infectious</mesh_term>
	<mesh_term>Staphylococcal Skin Infections</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Daptomycin</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<mesh_term>Methicillin</mesh_term>
	<criteria>≥18 year age Primary reason hospitalization skin skin structure infection complicate nature ( example , cellulitis/erysipelas , major cutaneous abscess , wound infection ) require IV antibiotic treatment anticipate 3 to14 day hospitalization management 1 . Further define infection either involve deep soft tissue require significant surgical intervention infection participant significant underlying disease state complicate response treatment 2 . Are suspected document caused MRSA 3 . At least 3 follow clinical sign symptom associate cSSSI : . Pain ; tenderness palpation ; ii . Elevated temperature ( &gt; 37.5°Celsius [ 99.5° Farenheit ] oral &gt; 38° Celsius [ 100.2° Farenheit ] rectal ) ; iii . Elevated white blood count ( WBC ) &gt; 10,000/millimeters cubed ( mm^3 ) ; iv . Swelling and/or induration ; erythema ; v. Purulent seropurulent drainage discharge Physician determination vancomycin daptomycin would initial treatment choice cSSSI study ( meet institutional criterion use vancomycin daptomycin ) Informed consent obtain sign Less 24 hour post hospital admission Participants know bacteremia , osteomyelitis , septic arthritis , endocarditis Conditions surgery ( ) constitute curative treatment infection ( example , amputation , incision drainage ) cSSSIs manage oral antibiotic Participants hospitalization expect &lt; 48 hour Nosocomial infection Participants necrotizing infection concomitant gangrene Use systemic antibacterial therapy infection &gt; 24 hour within 48 hour prior start study drug unless ( ) infect Grampositive pathogen resistant vitro therapy ( b ) therapy administer 3 day either worsen improvement infection Pathogens identify study entry nonsusceptible daptomycin vancomycin Participants neutropenia compromise immune function ( , severe neutropenia [ absolute neutrophil count &lt; 500 cell per microliter ( μL ) ] anticipate develop severe neutropenia study period due prior plan therapy ) Renal insufficiency ( calculated creatinine clearance [ CLcr ] &lt; 30 milliliter per minute dialysis ) Known allergic intolerant daptomycin vancomycin Pregnant nursing mother Suspected implanted device prosthetic source infection Is consider unlikely comply study procedure available followup contact</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Complicated Skin Skin Structure Infections ( cSSSI )</keyword>
	<keyword>Methicillin-resistant Staphylococcus aureus ( MRSA )</keyword>
	<keyword>Daptomycin</keyword>
	<keyword>Vancomycin</keyword>
	<keyword>Antibiotics</keyword>
</DOC>